OnKure Therapeutics (OKUR) Revenue (2024 - 2026)
Analysis
OnKure Therapeutics (OKUR) Revenue (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,124.12 Bn | 1,092.71 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 634.38 Bn | 554.24 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 505.39 Bn | 478.50 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 357.36 Bn | 311.74 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 290.21 Bn | 254.20 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 265.21 Bn | 238.89 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.81 Bn | 193.21 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 15.03 Bn |
| 10 | OnKure Therapeutics | 126.67 Mn | -371.26 Mn | - | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 458,000.00 |
| Dec 31, 2025 | 622,000.00 |
| Sep 30, 2025 | 802,000.00 |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | -44,000.00 |
| Jun 30, 2024 | 204,000.00 |
API Access
OnKure Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=OKUR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();